Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Consolidated Net IncomeDepreciation & Amortization - TotalEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Gross ProfitIncome from Continuing OperationsIncome towards Parent CompanyInterest & Investment IncomeNet Income towards Common StockholdersNon Operating IncomeOperating ExpensesOperating IncomeOther Non Operating IncomeOther Operating ExpensesProfit After TaxResearch & DevelopmentRevenueSelling, General & AdministrativeShares OutstandingShares Outstanding (Diluted Average)Shares Outstanding (Weighted Average)Tax ProvisionsTax Rate
Others
Ratios

Firefly Neuroscience (AIFF) Shares Outstanding (2016 - 2025)

Firefly Neuroscience has reported Shares Outstanding over the past 15 years, most recently at $14.0 million for Q4 2025.

  • Quarterly results put Shares Outstanding at $14.0 million for Q4 2025, changed N/A from a year ago — trailing twelve months through Dec 2025 was $14.0 million (changed N/A YoY), and the annual figure for FY2025 was $14.0 million, changed.
  • Shares Outstanding for Q4 2025 was $14.0 million at Firefly Neuroscience, up from $13.5 million in the prior quarter.
  • Over the last five years, Shares Outstanding for AIFF hit a ceiling of $15.2 million in Q3 2021 and a floor of -$1.5 million in Q4 2023.
  • Median Shares Outstanding over the past 5 years was $4.3 million (2023), compared with a mean of $6.5 million.
  • Biggest five-year swings in Shares Outstanding: tumbled 86.27% in 2022 and later soared 5285.91% in 2025.
  • Firefly Neuroscience's Shares Outstanding stood at $1.9 million in 2021, then increased by 10.21% to $2.1 million in 2022, then surged by 76.77% to $3.7 million in 2023, then skyrocketed by 130.42% to $8.5 million in 2024, then surged by 64.75% to $14.0 million in 2025.
  • The last three reported values for Shares Outstanding were $14.0 million (Q4 2025), $13.5 million (Q3 2025), and $13.3 million (Q2 2025) per Business Quant data.